Hyundai Steel Company

Seoul National University

Postech Academy-industry Foundation

Jun Ho Chung

Won Hoe Kim

Hyun Sub Kim

Jung Wook Park

Tae Hyung Kim

Young Jin Cho

Sung Ho Ryu

Se Jin Kim

Hyo Soo Kim

Sang Eun Lee

Kyung Lock Kim

Young Bae Park

Yoo Wook Kwon

Sahmin Lee

Hyo Dong Shin

Ji Ho Yoo

Seong-Ju Kim

Yoon Sup Choi

Hyun Chae Lee

Hyun Soo Cho

Kyoung Rok Lim

Ju Sang Lee

Sang Uk Kim

Su Min Yoon

A steel reinforcing bar contains 0.06 wt % to 0.11 wt % carbon, more than 0 and not more than 0.25 wt % silicon, 0.8 wt % or more and less than 2.0 wt % manganese, more than 0 and not more than 0.01 wt % phosphorus, more than 0 and not more than 0.01 wt % sulfur, 0.01 to 0.03 wt % aluminum, 0.50 to 1.00 wt % nickel, 0.027 to 0.125 wt % molybdenum, more than 0 and not more than 0.25 wt % chromium, more than 0 and not more than 0.28 wt % copper, more than 0 and not more than 0.01 wt % nitrogen, and the remainder being iron and unavoidable impurities. The reinforcing bar has a surface layer and a core. The surface layer has a hardened layer of tempered martensite, and the core has a mixed structure of bainite, ferrite and pearlite.

Steel reinforcing bar and production method therefor

A method for manufacturing a high-strength steel bar can include the steps of: reheating a steel slab at a temperature ranging from 1000&#xb0; C. to 1100&#xb0; C., the steel slab including a certain amount of carbon (C), silicon (Si), manganese (Mn), phosphorus (P), sulfur (S), chromium (Cr), copper (Cu), nickel (Ni), molybdenum (Mo), aluminum (Al), vanadium (V), nitrogen (N), antimony (Sb), tin (Sn), and iron (Fe) and other inevitable impurities, The method can further include finish hot-rolling the reheated steel slab at a temperature of 850&#xb0; C. to 1000&#xb0; C., and cooling the hot-rolled steel to a martensite transformation start temperature (Ms (&#xb0; C.)) through a tempcore process.

High-strength reinforcing steel and method for manufacturing same

A high-strength steel sheet according to the present invention comprises, by weight, 10.0-15.0% Mn, 6.0-9.0% Al, 0.5-2.0% Cr, 0.8-1.6% C, and 0.001-0.01% N, and further comprises, by weight, 0.02-0.1% V, 0.005-0.015% Nb, and 0.005-0.02% Mo, or further comprises 0.1-0.5 wt % TiAl particles. The high-strength steel sheet has a mixed structure comprising austenite and a fine k-carbide having a mean particle diameter of 10-500 nm.

High-strength steel sheet and manufacturing method therefor

The present invention concerns a human resistin receptor. More particularly, the present invention provides a method for screening a receptor of human resistin protein, a method for preventing or treating an inflammatory disease and arteriosclerosis using an expression- or activity-regulator for a human resistin receptor, and a pharmaceutical composition including an expression- or activity-regulator for the human resistin receptor. The method for screening a human resistin protein receptor according to the present invention enables separation of a receptor which directly binds to resistin from human monocyte, reveals a mechanism of signal transduction of the resistin receptor, and therefore, is expected to contribute to regulation of an inflammatory effect of monocyte, molecular detection of causes for vascular inflammation and arteriosclerosis, and developments of prevention and a treating agent for an inflammatory disease and arteriosclerosis.

Human resistin receptor and use thereof

The present invention relates to a method for preparing a target-specific non-antibody protein, and more particularly, to a method for preparing a target-specific non-antibody protein comprising the steps of: selecting non-antibody proteins having a structural complementarity with the target site of a target protein in a non-antibody protein library; calculating a binding energy of the selected non-antibody protein and the target protein; selecting a non-antibody protein having a favorable binding energy among the selected non-antibody proteins; selecting amino acid residues having a high binding energy among the interfacial amino acid residues of the selected non-antibody protein and the target protein; and substituting the selected amino acid residues with the amino acid residues having a low binding energy. In addition, the present invention relates to a target-specific non-antibody specifically binding with EGFR (Epidermal Growth Factor Receptor) domain 2, which is prepared by the method, and a cancer therapeutic composition comprising the same.

Target-specific non-antibody protein and method for preparing the same

Growing community of inventors

Seoul, South Korea

Jun Ho Chung